Adult Viral Hepatitis Coordinators
Go to page
Americans with Disabilities Act
Go to page
AASLD PRACTICE GUIDELINE
Diagnosis, Management, and Treatment of Hepatitis C
View PDF document
Aspects of HIV and HCV
Go to page
The Biopsy Report: A Patient's Guide
View PDF document
Books
Go to page
Burden of Hepatitis C Infection: Realities and Challenges
Hashem B. El-Serag, MD, MPH
View PDF document
CAM and Hepatitis C: A Focus on Herbal Supplements
View PDF document
Care for Patients Coinfected with HIV-HCV:
New Consensus Guidelines from an International Panel
View document
Chronic Hepatitis C in the Latino population
View PDF document
Chronic hepatitis C in Minority Populations
View PDF document
Chronic Hepatitis C During Pregnancy
Go to page
Consequences of Hepatitis C Virus (HCV):
Costs of a Baby Boomer Epidemic of Liver Disease
View PDF document
Counseling Guidelines
Go to page
Diet and Your Liver
Go to page
Disability Benefits Available from the Social Security Administration
View PDF document
Effects of Pegylated Interferon Alfa-2b on the Pharmacokinetic
and Pharmacodynamic Properties of Methadone:
A Prospective, Nonrandomized, Crossover Study in Patients Coinfected with Hepatitis C and HIV Receiving Methadone Maintenance Treatment
View PDF document
Epidemiology, Modes of Transmission,
& Risk Factors for Hepatitis C Virus (HCV) Infection
View PDF document
Estimating Future Hepatitis C Morbidity,
Mortality, and Costs in the United States
View PDF document
Facing Hepatitis C, Info You Need (downloadable brochure)
Download Brochure
Glossary
Go to page
HALT-C Trial Shows Minimal Long-term Benefit of Pegylated
Interferon Alfa-2a (Pegasys) Maintenance Therapy in Patients with Chronic Hepatitis C
View PDF document
Hepatitis A
Go to page
Hepatitis B
Go to page
Herbs that may Harm the Liver
Go to page
Interferon Alpha Therapy for Hepatitis C: Treatment Completion
and Response Rates Among Patients with Substance Use Disorders
Go to page
Medication and the Liver
Go to page
Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of
Illicit Drug Injection: The Influence of Time and Place
Holly Hagan, Enrique R. Pouget, Don C. Des Jarlais, and Corina Lelutiu-Weinberger
View PDF document
National Institutes of Health
Consensus Development Conference Statement
Management of Hepatitis C: 2002
June 10–12, 2002
View PDF document
National Institutes of Health Consensus Development
Conference Statement:
Management of Hepatitis B
View PDF document
New Directions in Hepatitis C Therapy: A Look at the Evolving Therapeutic Arsenal
View PDF document
Ongoing Challenges in the Management of Chronic Hepatitis C
View PDF document
Pain Killers and the Liver
Go to page
Product Development
Go to page
Successful Treatment of Chronic Hepatitis C with Pegylated Interferon in
Combination with Ribavirin in a Methadone Maintenance Treatment Program
View PDF document
Treatment for Co-occurring Substance Abuse and Hepatitis C
View PDF document
Treating the Methadone Patient
View PDF document
What's Cirrhosis?
Go to page